Help
RSS
API
Feed
Maltego
Contact
Domain > www.benefix.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-01-21
172.64.154.167
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sat, 05 Oct 2024 19:49:09 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Sat, 05 Oct 2024 20:49:09 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sat, 05 Oct 2024 19:49:09 GMTContent-Type: text/htmlTransfer-Encoding: chunkedConnection: keep-aliveCF-Ray: 8cdfeeebcfe4efbe-PDXCF-Cache-Status: HITAccept-Ranges: bytesCache-Contr !doctype html>html langen>head> meta contentieedge http-equivx-ua-compatible> meta nameviewport contentwidthdevice-width, initial-scale1.0> meta charsetutf-8> title>Home | BeneFɪx (Coagulation Factor IX Recombinant) | Safety Info/title> link relicon typeimage/x-icon hrefhttps://www.benefix.com/favicon_11396187.ico /> link relcanonical href/home /> meta namedescription contentSee risks & benefits. Learn about BeneFɪx (Coagulation Factor IX Recombinant) for once-weekly prophylaxis and on-demand use in patients with hemophilia B. /> meta namekeywords content /> meta nameabstract content /> meta namelanguage contenten /> meta namewebsite-brand contentBENEFIX /> meta namecountry contentUnited States /> meta propertydpl:page:pageType content> meta propertydpl:page:primaryMessageCategory content> meta propertydpl:page:pageSource contentPfizer> meta propertydpl:page:contentOrigin contentoriginal> meta propertydpl:page:GCMA-ID content> meta namepage-analytics contentpageType:null;referringUrl:;language:en;currencyCode:USD;primaryMessageCategory:null;pageSource:null;contentOrigin:null;contentID:page/59590d25-eb00-420f-9c13-61820e8e90de;country:United States;GCMA-ID:PP-BEN-USA-0498;GCMA-page-ID:;trackingCode:;platform:Canvas;sessionID:;siteName:;pageName:;pageURL:;onetag:;brand:BENEFIX;indication:Bleeding disorder, Hemophilia B;audienceType:Patient;audienceSpecialty:Patients;businessUnit:RARE DISEASE;contentType:Website;therapeuticArea:No Therapeutic Area;region:Americas;pfizerRegion:NA /> meta propertyog:title contentHome | BeneFɪx (Coagulation Factor IX Recombinant) | Safety Info /> meta
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]